Everything by us and about us

Most companies already have a localization workflow. It might have been built during an early expansion push, or inherited from a vendor. In some cases, it came with the implementation of a translation management system, or TMS, sometimes without much training or customization. Whatever its origin, the workflow is probably still in place and still […]

Join Stephanie Harris-Yee and Erik Vogt for a thought-provoking discussion on how artificial intelligence is transforming marketing beyond just accelerating content production. This conversation explores the shifting paradigm from content volume to precision targeting and the evolving role of localization in an AI-driven marketing landscape. Key topics covered: The changing bottleneck from production to audience […]

AI remains a hot topic in localization right now. It shows up in conference panels and RFPs and there’s a lot of curiosity, urgency, and noise. But what’s still rare are examples of where AI is working well in practice. This creates some risks. It’s easy to talk about potential and efficiency gains in theory, […]

AI-Powered Quality Assurance in Localization Join Stephanie Harris-Yee and Erik Vogt for an in-depth exploration of AI LQA (Linguistic Quality Assurance) and its transformative impact on the localization industry. This conversation delves into how artificial intelligence is enhancing quality control processes and reshaping traditional approaches to translation quality assessment. Key topics covered: The current state […]

AI is here. It’s showing up in RFPs, boardroom presentations, and internal conversations, and localization teams are feeling the pressure to act. But knowing you need to do something with AI isn’t the same as knowing where to start, how much to change, or what’s actually worth the risk. For most localization programs, the fear […]

Argos Multilingual surveyed nearly 1,000 people across eight countries to understand how users interact with GenAI-generated content. The findings, published in our report, The End-User in the Loop, point to a recurring problem: content that clears internal review often fails when it reaches the people it was meant to help. Fluency and formatting don’t guarantee […]

In April 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) implemented a revised clinical trials framework following its public consultation on regulatory reform. Sponsors are now expected to submit through the Combined Review, a coordinated ethics and regulatory process with a target timeline of 150 days. It changes what gets submitted, when, and […]